A man walked into his pharmacy last week. His diabetes pills rang up at $330. Same pills. Same box. Same brand. He typed the drug's name into a new government website. He paid $100.

I can't stop thinking about this. That $230 gap didn't just vanish. It was going somewhere for years. And the folks it was going to are sitting in your retirement account.

On Monday, the Trump administration is expected to announce another round of drug deals. This time with midsize biotech firms. Fourteen of the seventeen biggest drug makers are already signed on. That's about 86% of every brand-name pill sold in America.

Here's what worries me. The story you'll hear is "cheaper drugs for Americans." That part is true. But it's not the whole story. The whole story is a quiet war on the middlemen. These middlemen hide in plain sight. They sit inside almost every portfolio in the country.

They're called pharmacy benefit managers. Three of them run the show. CVS Caremark. OptumRx, which UnitedHealth owns. And Express Scripts, owned by Cigna. Between them, they touch 8 out of every 10 prescriptions filled in this country.

That's about 6.6 billion prescriptions a year. And these three companies pull in around $557 billion doing it. Half a trillion dollars. Just for standing between us and the pharmacy shelf.

They take a cut when the drug maker sells. A cut when the pharmacy fills. Rebates. Fees. Something called spread pricing. They pay the pharmacy one price. They charge your insurance a higher one. Nobody sees it. Nobody argues with it. That $230 you never saw on your diabetes bill? A lot of it fed this machine.

These middlemen grew in the dark for twenty years. They started as small firms handling paperwork. Then the paperwork became the business. Now they own mail-order pharmacies. They own the software your doctor uses to pick your pill. They set the price at the counter. And most of us never learned their names.

Jeff Brown believes by the end of this month, this Elon Musk new AI breakthrough will collide…

With a powerful market prophecy that has correctly predicted some of the biggest market booms going back to 1950…

Giving Americans a rare and perhaps last chance to turn a small stake into an entire six-figure nest egg in the next 12-18 months.

The last time something like this happened, investors had a chance to turn a small stake of $10,000 into as much as $366,000 in just 14 months.

TrumpRx‎.‎‎gov went live in February. It skips the middlemen. You go to a website. You pay cash. You get the pill. That's the whole thing.

You can buy Merck's Januvia there for $100 instead of $330. Amgen's cholesterol drug Repatha for $239 instead of $573. Nine of the middlemen just agreed to show TrumpRx prices inside their own tools. That's not a partnership. That's a white flag.

The drug makers used to play along. They paid the middlemen. They took the smaller check. Now they're cutting the deal directly with the government. Cheaper for you. Bigger check for them. Nothing left for the folks in the middle.

I get it. Cheaper drugs sound like a win. And for our neighbors filling scripts at 65, they are. But nothing this big comes for free.

I don't think most people realize how much of this sits in our index funds. UnitedHealth is a Dow stock. It's one of the biggest holdings in the S&P 500. If you own a target-date fund, you own a piece of it. If you have a 401(k) that just tracks the market, same thing. Millions of us do. We didn't sign up for this fight. We just showed up for retirement.

Trump has said out loud that he wants to "knock them out." He called them "horrible middlemen." He made a smaller version of that comment back in December 2024. CVS Health dropped 4.3% in a single day. UnitedHealth lost 3.9%. Cigna gave up 2.6%.

That was one comment. One day. And Monday is the next domino.

Monday isn't the big names. It's smaller biotech firms. But that's the point. The big drug makers already folded. Now the smaller ones are lining up. Every deal is another prescription that skips the middleman. Another dollar that used to feed a machine most of us can't name.

Pull up your account statement this weekend. Look for a fund that says "S&P 500" or "total market" or "Dow." That fund holds UnitedHealth. It holds CVS. It holds Cigna. Not because you picked them. Because everybody does.

I don't know how far this goes. Nobody knows. Even the folks running these companies don't know. That's the part that gets me. A $557 billion industry is being pulled apart on live TV. And the people who own it don't even know they own it.

I keep picturing that pharmacy counter. The man. The $230 he didn't spend. And somewhere on a company balance sheet, a room that used to be full is starting to empty out. That empty room might be in your fund too.

More on this tomorrow.

— American Ledger